Interventional Cardiology & Surgery
Conference Coverage
FAVOR III China: QFR-guided PCI shows advantage over angiography
Results from sham-controlled study strengthen support for using physiology to guide percutaneous coronary interventions, but external validation...
From the Journals
How applicable is ISCHEMIA trial to U.S. clinical practice?
A new study suggests that less than a third of U.S. patients with stable ischemic heart disease who currently undergo intervention would meet the...
Conference Coverage
FFR-guided PCI falls short vs. surgery in multivessel disease: FAME 3
PCI guided by FFR assessment may have yielded better outcomes in patients with less complex coronary anatomy, researchers say; others doubt the...
Conference Coverage
SUGAR trial finds superior stent for those with diabetes and CAD
In noninferiority trial, the Cre8 EVO stent was associated with fewer target lesion failures than the Resolute Onyx at 1 year in the setting of...
Conference Coverage
Renal denervation remains only promising, per latest meta-analysis
A fairly large body of evidence showing safety and efficacy for renal denervation is not enough for an indication.
News
FDA class I recall of CardioSave hybrid/rescue IABPs
Subpar batteries were mistakenly released to a limited number of customers and may have a shortened run time and fail unexpectedly.
Conference Coverage
Real-world data favor invasive strategy for NSTEMI with CKD
The clinical benefits of initial invasive management came with a “minimal increased risk” of in-hospital acute kidney injury and major bleeding in...
From the Journals
AHA: Quality of STEMI care has stalled, needs improvement
A new American Heart Association policy statement recommends actions to improve care for people who have ST-segment elevation MI.
From the Journals
Most women born with heart defects can become pregnant and give birth safely
Most women with congenital heart defects can safely become pregnant and give birth to healthy babies, results of a new study in Germany suggest....
From the Journals
Pacemakers after TAVR: No long-term survival differences
“To date, the impact of PPI on late clinical outcomes after TAVR remains controversial; however, this study to some extent helps clarify this...
Conference Coverage
FDA investigating potential sex differences in LAAO adverse outcomes
“The FDA recognizes the limitations of these data, including that the study was not randomized, only included one LAAO device (the first-...